Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LungstarPK: Pravastatin with cisplatin + docetaxel in NSCLC
2007-002411-36Phase 2Terminated
- Sponsor
- Imperial College London
- Start
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of pravastatin in non-small cell lung cancer (NSCLC), sponsored by Imperial College London. Primary endpoints: Pharmacokinetics of docetaxel and cisplatin with pravastatin and Safety and tolerability of pravastatin with docetaxel and cisplatin. Started Oct 2007; status: terminated.
02
Drugs
pravastatin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on 2007-002411-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002411-36.